Evidence map›Paper›PMID 33615105›Full record

ArticleJBMR plus2021

Burden of Disease in Patients With Tumor-Induced Osteomalacia.

Fernando Jerkovich, Selva Nuñez, Yamile Mocarbel, Analía Pignatta, Natalia Elías, Hamilton Cassinelli, Adriana Graciela Díaz, Carlos Vigovich, María Celeste Balonga, Ana Carolina Cohen and 4 more

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review.The Journal of clinical endocrinology and metabolism · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. A literature review to understand the burden of disease in people living with tumour-induced osteomalacia.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Review
  11. A mysterious case of recurrent fracture: Tumour-induced osteomalacia.Journal of family medicine and primary care · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Fernando JerkovichInstituto Diagnóstico e Investigaciones Metabólicas, Universidad del Salvador Buenos Aires Argentina.
Selva NuñezInstituto Diagnóstico e Investigaciones Metabólicas, Universidad del Salvador Buenos Aires Argentina.
Yamile MocarbelDivisión Endocrinología, Hospital de Clínicas Universidad de Buenos Aires Buenos Aires Argentina.
Analía PignattaServicio de Endocrinología Hospital Interzonal San Juan Bautista San Fernando del Valle de Catamarca Argentina.
Natalia ElíasServicio de Endocrinología, Metabolismo, Nutrición y Diabetes Hospital Británico de Buenos Aires Buenos Aires Argentina.
Hamilton CassinelliCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Fundación de Endocrinología Infantil (FEI) - División de Endocrinología Hospital de Niños Ricardo Gutiérrez Buenos Aires Argentina.
Adriana Graciela DíazDivisión Endocrinología, Hospital de Clínicas Universidad de Buenos Aires Buenos Aires Argentina.
Carlos VigovichHospital Gobernador Centeno General Pico Argentina.
María Celeste BalongaInstituto Diagnóstico e Investigaciones Metabólicas, Universidad del Salvador Buenos Aires Argentina.
Ana Carolina CohenSanatorio Rivadavia San Miguel de Tucumán Argentina.
Giselle MumbachInstituto de Ortopedia y Traumatología Posadas Argentina.
Sofía GonzalezHospital Lagomaggiore Mendoza Argentina.
José Rubén ZanchettaInstituto Diagnóstico e Investigaciones Metabólicas, Universidad del Salvador Buenos Aires Argentina.
María Belén ZanchettaInstituto Diagnóstico e Investigaciones Metabólicas, Universidad del Salvador Buenos Aires Argentina.ORCID https://orcid.org/0000-0002-9397-1847
Universidad del Salvador · ARUniversidad de Buenos Aires · ARCentro Científico Tecnológico - Tucumán · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AREuro-Centrum · PLHospital Británico de Buenos Aires · ARHospital Posadas · ARNational University of Catamarca · ARUniversity of Mendoza · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-induced osteomalacia (TIO) is a chronic condition associated with muscle weakness and long-term disability. We conducted a cross-sectional study of patients diagnosed with TIO who had been referred to our institution between May 2018 and December 2019. Our aim was to assess health-related quality of life (HRQoL), fatigue, pain, and muscle mass and strength in these patients. Detailed information was obtained regarding general characteristics, initial symptoms and biochemical parameters measured at diagnosis and on the first visit to our institution. Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale, pain using the Brief Pain Inventory-Short Form (BPI-sf) scale and HRQoL by the 36-item Short Form survey (SF-36) questionnaire. Eight patients were included in the study: three without tumor localization, four with nonremission after surgery, and one with clinical recurrence 2 years after surgery. Fatigue experienced by patients with TIO was significantly higher compared to the general population (

Indexed as

BONE PAINFATIGUEHEALTH‐RELATED QUALITY OF LIFEMUSCLE STRENGTHTUMOR‐INDUCED OSTEOMALACIA

Identifiers

PMID33615105
PMCPMC7872334
OpenAlexW3099224037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.